Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
78.60    1.70 (2.21%)
Bid:
78.30
Ask:
78.50
Spread: 0.20 (0.255%)
Market Cap: £378.05m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Portfolio Update

29 Jun 2021 07:00

RNS Number : 3998D
Chrysalis Investments Limited
29 June 2021
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.

 

 

29 June 2021

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

 

The Company is pleased to announce its Investment Adviser, Jupiter Investment Management Limited has entered into a cornerstone investment agreement with Revolution Beauty Group plc ("Revolution Beauty") as part of its expected IPO, and that the Company anticipates investing approximately £45 million as part of this process. Further details are available in Revolution Beauty's Intention to Float announcement that has been released today.

 

Chrysalis met Revolution Beauty as part of a "pilot fishing" (a pre-IPO exploratory meeting) exercise at the request of the latter's CEO, Adam Minto, due to the Company's ability to invest both privately and publicly. Having analysed the investment case for Revolution Beauty and undertaken channel checks on the brand, the Investment Adviser believes it has a significant runway for growth.

 

Chrysalis has the ability to invest up to 20% of gross assets in companies it has not held prior to IPO, calculated at the point of investment. While the Company's primary goal is to secure access to exciting companies prior to their IPOs and capture their subsequent growth in private markets, one of its other aims is to position itself favourably at point of IPO to secure a good allocation. Given the work undertaken by the Investment Adviser in assessing this potential transaction, it believes it will be a very attractive investment for shareholders.

 

The main focus of Chrysalis will remain sourcing private, late-stage investments - typically two to five years out from IPO - but the Investment Adviser will continue to be flexible in its approach to leveraging its proposition to maximise value generation for shareholders.

 

Nick Williamson and Richard Watts (co-portfolio managers) comment:

 

"Over the last seven years, Adam and Tom have built an amazing company, able to bring exciting products that customers want to market significantly faster than its competition. With a small market share in a huge market and a compelling customer proposition, we believe Revolution Beauty is well placed to grow aggressively in the years ahead."

 

Adam Minto (CEO of Revolution Beauty) comments:

 

"Chrysalis has developed a compelling proposition for entrepreneurs with late-stage businesses, providing long-term capital regardless of whether they stay private or choose to go public. We are looking forward to a successful IPO and will be proud to welcome Chrysalis onto our shareholder list, as part of the wider cornerstone agreement with Jupiter".

 

About Revolution Beauty

 

Revolution Beauty was founded by Adam Minto (CEO) and Tom Allsworth (Executive Chairman) in 2014, since when it has experienced a revenue CAGR of 99% to December 2019, with the year to December 2020 showing minimal growth due to COVID-19.

 

Revolution Beauty operates a "digital first" strategy, but has multiple channels to market for its various brands, which cover a number of different beauty categories. The company differentiates itself with its speed to market: it looks to identify beauty trends quickly and bring them to the mass-market within 16 weeks, making it significantly more agile and responsive than its global competitors, which typically take 6 to 12 months. It identifies trends via consumers, influencers and retailers, particularly via social media platforms, such as Instagram and TikTok. It then utilises its highly efficient and scalable supply chain to bring products to market rapidly, digesting customer responses, before fine-tuning. Revolution Beauty is committed to sustainability, by ensuring products ranges are 100% cruelty free, mostly vegan, and sustainable and recyclable packaging are used wherever possible.

 

Revolution Beauty's core offering is in colour cosmetics, but it expanded into skincare in 2018 and has relaunched its haircare range in 2021. In total, this offers an addressable market of approximately $197 billion in 2021, growing at a CAGR of 6% to 2025 (Source: Euromonitor).

 

Over the fourteen months to 28 February 2021, Revolution Beauty generated revenues of £157.6 million and adjusted EBITDA of £13.1 million.

 

-ENDS-

 

 

 

For further information, please contact:

 

Media:

Montfort Communications

Charlotte McMullen/ Toto Reissland-Burghart/ Miles McKechnie

 

 

 

 

+44 (0) 20 3770 7920

chrysalis@montfort.london

 

Jupiter Asset Management:

Magnus Spence

 

+44 (0) 20 3817 1325

Liberum:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown/ Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at

https://www.chrysalisinvestments.co.uk/

 

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFVLLLFQLEBBX
Date   Source Headline
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20262:58 pmRNSBoard clarification in response to stmt by CIP
20th Feb 20267:02 amRNSTransaction in Own Shares
20th Feb 20267:01 amRNSPropose New Inv Policy New Mgmt Arr. Notice of EGM
20th Feb 20267:00 amRNSAppointment of Director
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202612:30 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:01 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20262:43 pmRNSTransaction in Own Shares
31st Dec 20257:01 amRNSDirector Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.